New cloud-based platform is being developed to integrate artificial intelligence, automated quality control and healthcare data connectivity to support next-generation precision medicine workflows.

Beijing, China, July 15, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (NASDAQ:ITOC) (the "Company"), a technology-driven healthcare company focused on developing innovative digital medical solutions, today announced continued progress in the development of its next-generation AI-enabled Treatment Planning System ("TPS") Cloud Platform through Mili (Jiangsu) Medical Technology Co., Ltd. ("Mili Medical"), a technology company focused on digital solutions for nuclear medicine and radiation treatment planning. The Company, through its indirect PRC subsidiary, has held a 60% equity interest in Mili Medical since its establishment. 

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.